# Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway

> **NCT00498134** · NA · UNKNOWN · sponsor: **Hospital Authority, Hong Kong** · enrollment: 1200 (estimated)

## Conditions studied

- Stomach Neoplasms

## Interventions

- **DRUG:** Triple therapy for H. pylori infection
- **DRUG:** Cox-2 inhibitor

## Key facts

- **NCT ID:** NCT00498134
- **Lead sponsor:** Hospital Authority, Hong Kong
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** 2013-04
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2010-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00498134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00498134, "Chemoprevention of Gastric Cancer by Intervention With Helicobacter Pylori and Cyclooxygenase Pathway". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00498134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*